More News

13 Dec 2021 Pfizer to Acquire Arena Pharmaceuticals
10 Dec 2021 Lilly and Regor Therapeutics Group Enter into Strategic Collaboration to Discover and Develop Novel Therapies for Metabolic Disorders
07 Dec 2021 Recordati to acquire EUSA Pharma (UK) Ltd, a global specialty pharmaceutical company focused on rare and niche oncology diseases
07 Dec 2021 AstraZeneca and Ionis sign deal to develop and commercialise eplontersen
03 Dec 2021 SOTIO Secures €280m of Funding to Expand and Advance Clinical Pipeline
02 Dec 2021 ITM and Navigo Proteins Announce Research Collaboration to Develop FAP-targeting Radionuclide Therapy to Address Solid Tumors
02 Dec 2021 UCB Announces Global Partnership To Bring Disease-Modifying Therapies To People Living With Parkinson's Disease
02 Dec 2021 Sanofi to acquire Origimm Biotechnology in first move to treat acne with vaccine-based immunotherapy
02 Dec 2021 Curie Therapeutics Raises $75 Million Financing to Further its Mission of Transforming Cancer Care with Precision Radiopharmaceuticals
30 Nov 2021 Ranok Therapeutics Announces Agreement with Pfizer on Targeted Protein Degradation
30 Nov 2021 Confo Therapeutics Enters Collaborative Agreement with Regeneron
30 Nov 2021 SciRhom augments seed financing to reach total funding of EUR 16 million
24 Nov 2021 Philogen announces new collaboration with Janssen to discover small molecule therapeutics
23 Nov 2021 Nykode Therapeutics (Formerly Vaccibody*)) Enters Into Multi-target License and Collaboration Agreement With Regeneron to Develop Innovative Vaccines Against Cancer and Infectious Diseases
23 Nov 2021 Arrowhead Pharmaceuticals Enters Exclusive License Agreement with GSK for ARO-HSD
22 Nov 2021 Baidu Enters Into License Agreement With Sanofi to Enable Next-Generation mRNA Therapeutics and Vaccines
22 Nov 2021 Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from Xencor
22 Nov 2021 Vifor Pharma to spearhead development of vascular calcification field, through acquisition of Sanifit Therapeutics and Inositec AG
19 Nov 2021 Gilead Exercises Options to Three Arcus Biosciences Clinical-Stage Programs and Adds Research Collaboration
18 Nov 2021 Novo Nordisk to acquire Dicerna Pharmaceuticals including the RNAi research technology platform
16 Nov 2021 SOTIO Expands its Antibody-Drug Conjugate Pipeline with Exclusive Collaboration and License Agreement with LegoChem Biosciences
16 Nov 2021 ACELYRIN, INC. Closes $250 Million Series B Financing and Announces Licensing of Izokibep, a Late-Stage IL-17A Inhibitor to Treat Inflammatory Diseases
16 Nov 2021 Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics for Difficult to Treat Diseases
16 Nov 2021 Recludix Pharma Launches with $60 Million Series A to Support Innovative Platform to Discover and Develop Novel SH2 Domain-Targeted Therapies for Cancer and Inflammatory Diseases; Appoints Dr. Nancy Whiting as CEO
12 Nov 2021 Organon to Acquire Forendo Pharma

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up